178 related articles for article (PubMed ID: 29217785)
1. Down syndrome-like acute megakaryoblastic leukemia in a patient with Cornelia de Lange syndrome.
Vial Y; Lachenaud J; Verloes A; Besnard M; Fenneteau O; Lainey E; Marceau-Renaut A; Preudhomme C; Baruchel A; Cavé H; Drunat S
Haematologica; 2018 Jun; 103(6):e274-e276. PubMed ID: 29217785
[No Abstract] [Full Text] [Related]
2. Acute megakaryoblastic leukemia and clonal trisomy 21 in a phenotypically normal infant.
Arico M
Blood; 1991 Jun; 77(11):2542-3. PubMed ID: 1828181
[No Abstract] [Full Text] [Related]
3. Development of acute megakaryoblastic leukemia from a minor clone in a Down syndrome patient with clinically overt transient myeloproliferative disorder.
Xu G; Kato K; Toki T; Takahashi Y; Terui K; Ito E
J Pediatr Hematol Oncol; 2006 Oct; 28(10):696-8. PubMed ID: 17023834
[TBL] [Abstract][Full Text] [Related]
4. Acute megakaryoblastic leukemia in Down syndrome: orbital infiltration.
Olson JL; May MJ; Stork L; Kadan N; Bateman JB
Am J Ophthalmol; 2000 Jul; 130(1):128-30. PubMed ID: 11004278
[TBL] [Abstract][Full Text] [Related]
5. A case of pentasomy 21 with two isochromosome 21s in acute megakaryoblastic leukemia associated with Down syndrome.
Park Y; Lim J; Ko YH; Kim J; Kwon GC; Koo SH
Ann Lab Med; 2015 May; 35(3):373-5. PubMed ID: 25932450
[No Abstract] [Full Text] [Related]
6. Highly sensitive detection of GATA1 mutations in patients with myeloid leukemia associated with Down syndrome by combining Sanger and targeted next generation sequencing.
Terui K; Toki T; Taga T; Iwamoto S; Miyamura T; Hasegawa D; Moritake H; Hama A; Nakashima K; Kanezaki R; Kudo K; Saito AM; Horibe K; Adachi S; Tomizawa D; Ito E
Genes Chromosomes Cancer; 2020 Mar; 59(3):160-167. PubMed ID: 31606922
[TBL] [Abstract][Full Text] [Related]
7. GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.
Pine SR; Guo Q; Yin C; Jayabose S; Levendoglu-Tugal O; Ozkaynak MF; Sandoval C
Leuk Res; 2005 Nov; 29(11):1353-6. PubMed ID: 15916804
[TBL] [Abstract][Full Text] [Related]
8. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
9. [Megakaryoblastic leukemia and transient abnormal myelopoiesis with Down's syndrome].
Suda J; Eguchi M
Rinsho Ketsueki; 1988 Aug; 29(8):1200-6. PubMed ID: 2974493
[No Abstract] [Full Text] [Related]
10. Eyelid mass as the presenting finding in a child with Down syndrome and acute megakaryoblastic leukemia.
Sandoval C; Davis A; Jayabose S
Pediatrics; 2005 Mar; 115(3):810-1. PubMed ID: 15741393
[TBL] [Abstract][Full Text] [Related]
11. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome.
Holt SE; Brown EJ; Zipursky A
J Pediatr Hematol Oncol; 2002 Jan; 24(1):14-7. PubMed ID: 11902731
[TBL] [Abstract][Full Text] [Related]
12. [Diffuse liver fibrosis associated with transient myeloproliferative disorder in Down's syndrome].
Villamor Zambrano E; Alonso Ortiz T; Arizcun Pineda J; Moro Serrano M
An Esp Pediatr; 1997 Jul; 47(1):69-70. PubMed ID: 9382333
[No Abstract] [Full Text] [Related]
13. GATA 1 mutations as clonal markers of minimal residual disease in acute megakaryoblastic leukemia of Down syndrome--a new tool with significant potential applications.
Hitzler J; Zipursky A
Leuk Res; 2005 Nov; 29(11):1239-40. PubMed ID: 15925405
[No Abstract] [Full Text] [Related]
14. Acute megakaryoblastic leukaemia with erythrophagocytosis.
Lobo-Olmedo A; Roldán Galiacho V; Arzuaga-Méndez J; Ancín I; García-Ruiz JC
Br J Haematol; 2021 Aug; 194(4):658. PubMed ID: 33934353
[No Abstract] [Full Text] [Related]
15. Cornelia de Lange syndrome due to mosaic NIPBL mutation: antenatal presentation with sacrococcygeal teratoma.
Banait N; Fenton A; Splitt M
BMJ Case Rep; 2015 Aug; 2015():. PubMed ID: 26276849
[TBL] [Abstract][Full Text] [Related]
16. Transient myelodysplasia in an infant with Down syndrome preceding acute megakaryoblastic leukemia: cytogenetic and immunophenotypic findings.
Rodrigues EF; da Costa ES; Land MG; Diamond HR; Ornellas MH; Abdelhay E; Fernandez Tde S
Cancer Genet Cytogenet; 2009 Jan; 188(1):54-6. PubMed ID: 19061782
[No Abstract] [Full Text] [Related]
17. [Congenital acute megakaryoblastic leukemia associated with trisomy 21].
Gomis F; Pérez Sirvent ML; Borrego D; Sempere A
Sangre (Barc); 1990 Dec; 35(6):485-6. PubMed ID: 2150895
[No Abstract] [Full Text] [Related]
18. The c-sis gene expression in cells from a patient with acute megakaryoblastic leukemia and Down's syndrome.
Sunami S; Fuse A; Simizu B; Eguchi M; Hayashi Y; Sugita K; Nakazawa S; Okimoto Y; Sato T; Nakajima H
Blood; 1987 Aug; 70(2):368-71. PubMed ID: 2955817
[TBL] [Abstract][Full Text] [Related]
19. Cornelia de Lange syndrome: evolution of the phenotype.
Passarge E; Mecke S; Altrogge HC
Pediatrics; 1971 Nov; 48(5):833-6. PubMed ID: 5121247
[No Abstract] [Full Text] [Related]
20. A series of 38 novel germline and somatic mutations of NIPBL in Cornelia de Lange syndrome.
Nizon M; Henry M; Michot C; Baumann C; Bazin A; Bessières B; Blesson S; Cordier-Alex MP; David A; Delahaye-Duriez A; Delezoïde AL; Dieux-Coeslier A; Doco-Fenzy M; Faivre L; Goldenberg A; Layet V; Loget P; Marlin S; Martinovic J; Odent S; Pasquier L; Plessis G; Prieur F; Putoux A; Rio M; Testard H; Bonnefont JP; Cormier-Daire V
Clin Genet; 2016 May; 89(5):584-9. PubMed ID: 26701315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
